论文部分内容阅读
目的 观察胸膜腔注入泛影葡胺治疗自发性气胸的临床效果。方法 采用 76 %的泛影葡胺注入胸膜腔治疗 4 7例自发性气胸 ,并与常规方法治疗的 4 2例进行对比。结果 治疗组 4 7例 ,其中 4 3例 (91 5 % )在施术后 4天内痊愈 ,其余 4例经胸膜闭锁或胸腔镜肺大疱摘除而愈 ;对照组 4 2例中有 32例 (76 2 % ) 4天内痊愈 ,两组比较有显著差异 (χ2 =3 876 ,P <0 0 5 )。治疗组 4 7例泛影葡胺注入胸膜腔后均出现不同程度的胸液增多 ,2 7例有轻度胸痛 ,9例有轻、中度发热 ,未发现明显毒副作用。结论 泛影葡胺注入胸膜腔有利于自发性气胸的愈合 ,而且方法简单、无明显毒副作用
Objective To observe the clinical effect of pleuromine injection of diatrizoate in the treatment of spontaneous pneumothorax. Methods Forty-seven patients with spontaneous pneumothorax were treated with 76% diatrizoate injection into the pleural cavity and compared with 42 patients treated with conventional methods. Results The treatment group 47 cases, of which 43 cases (91.5%) recovered within 4 days after the operation, and the remaining 4 cases were removed by pleural atresia or thoracoscopic pneumocystis and more; in the control group of 42 cases, 32 cases ( 76 2%) recovered within 4 days, there was a significant difference between the two groups (χ2 = 3876, P <0 05). In the treatment group, 47 cases of meglumine diatrizoate were injected into the pleural cavity with pleural effusion, 27 cases had mild chest pain, 9 cases had mild to moderate fever, and no obvious side effects were found. Conclusions The injection of diatrizoate into the pleural cavity is good for the healing of spontaneous pneumothorax, and the method is simple and has no obvious side effects